Alex Goldberg

NYSE Active Stock Watch List: Joy Global, Inc. (NYSE:JOY) and Puma Biotechnology, Inc. (NYSE:PBYI) Added to Equity Profile Report's NYSE Active Stock Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/10/2013 -- Equity Profile Report expands its NYSE Active Stock Weekly Watch List adding Joy Global, Inc. (NYSE:JOY) and Puma Biotechnology, Inc. (NYSE:PBYI).

Joy Global, Inc. (NYSE:JOY) a company that engages in the manufacture and servicing of mining equipment for the extraction of coal, copper, iron ore, oil sands, and other minerals closed up in its previous session (+0.55%) on 1,787,407 shares traded. Joy Global, Inc. (NYSE:JOY) is currently up (+19.13%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.

Click Here to find out what other Investors are saying about Joy Global, Inc. (NYSE:JOY)

Puma Biotechnology, Inc. (NYSE:PBYI) a development stage biopharmaceutical company that engages in the acquisition, development, and licensing of products for the treatment of various forms of cancer closed down in its previous session (-6.02%) on 700,616 shares traded. Puma Biotechnology, Inc. (NYSE:PBYI) is currently down (-8.34%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Active Stock Watch List.

Click Here to find out what other Investors are saying about Puma Biotechnology, Inc. (NYSE:PBYI)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com